Nasdaq celebrates record biotech IPO success in 2018. But can the party on Wall Street rumba on?

Nasdaq celebrates record biotech IPO success in 2018. But can the party on Wall Street rumba on?

Source: 
Endpoints
News Tags: 
snippet: 

On Thursday night Moderna $MRNA proved that a unicorn can still raise record sums with a biotech IPO on Nasdaq. And by the time the market closed Friday, the 20% drop in their share price also had more than a few people wondering if the party on Wall Street was finally winding down.